Longitudinal dynamics of the tumor hypoxia response: From enzyme activity to biological phenotype.
Sandy Che-Eun Serena LeeAndrea Hye An PyoMarianne KoritzinskyPublished in: Science advances (2023)
Poor oxygenation (hypoxia) is a common spatially heterogeneous feature of human tumors. Biological responses to tumor hypoxia are orchestrated by the decreased activity of oxygen-dependent enzymes. The affinity of these enzymes for oxygen positions them along a continuum of oxygen sensing that defines their roles in launching reactive and adaptive cellular responses. These responses encompass regulation of all steps in the central dogma, with rapid perturbation of the metabolome and proteome followed by more persistent reprogramming of the transcriptome and epigenome. Core hypoxia response genes and pathways are commonly regulated at multiple inflection points, fine-tuning the dependencies on oxygen concentration and hypoxia duration. Ultimately, shifts in the activity of oxygen-sensing enzymes directly or indirectly endow cells with intrinsic hypoxia tolerance and drive processes that are associated with aggressive phenotypes in cancer including angiogenesis, migration, invasion, immune evasion, epithelial mesenchymal transition, and stemness.
Keyphrases
- endothelial cells
- epithelial mesenchymal transition
- dna methylation
- genome wide
- gene expression
- machine learning
- squamous cell carcinoma
- oxidative stress
- transforming growth factor
- signaling pathway
- vascular endothelial growth factor
- mass spectrometry
- cell proliferation
- cell migration
- squamous cell
- cell death
- sensitive detection
- cancer stem cells